Doctor discusses 3-drug clinical trial for COVID treatment
Clip: 12/01/2020 | 3m 49s | Video has closed captioning.
Rutgers are leading a clinical trial using a three-drug combination to assess if the medications, when taken together, can shorten the duration of COVID-19. Researchers are looking for adults who are COVID-19-positive within one week and who are not in the hospital.
Problems Playing Video? | Closed Captioning